Silk Road Medical, Inc
SILK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $177 | $139 | $101 | $75 |
| % Growth | 27.8% | 36.6% | 34.9% | – |
| Cost of Goods Sold | $50 | $38 | $25 | $21 |
| Gross Profit | $127 | $101 | $76 | $54 |
| % Margin | 71.7% | 72.7% | 74.9% | 71.7% |
| R&D Expenses | $41 | $36 | $27 | $21 |
| G&A Expenses | $145 | $116 | $96 | $75 |
| SG&A Expenses | $145 | $116 | $96 | $76 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $186 | $153 | $123 | $97 |
| Operating Income | -$59 | -$52 | -$47 | -$43 |
| % Margin | -33.5% | -37.5% | -46.8% | -57% |
| Other Income/Exp. Net | $4 | -$3 | -$2 | -$5 |
| Pre-Tax Income | -$56 | -$55 | -$50 | -$47 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$56 | -$58 | -$50 | -$50 |
| % Margin | -31.5% | -41.8% | -49.7% | -67% |
| EPS | -1.44 | -1.62 | -1.45 | -1.53 |
| % Growth | 11.1% | -11.7% | 5.2% | – |
| EPS Diluted | -1.44 | -1.62 | -1.45 | -1.53 |
| Weighted Avg Shares Out | 39 | 36 | 35 | 33 |
| Weighted Avg Shares Out Dil | 39 | 36 | 35 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $3 | $0 | $1 |
| Interest Expense | $7 | $5 | $3 | $4 |
| Depreciation & Amortization | $4 | $3 | $2 | $1 |
| EBITDA | -$45 | -$47 | -$46 | -$41 |
| % Margin | -25.4% | -33.7% | -44.9% | -55.1% |